Osaic Holdings’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Osaic Holdings’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-557	Closed	-$221	–	7645
2023 Q3	$221	Sell	557 -30,057	-98%	-$14.8K	﹤0.01%	7138
2023 Q2	$21.1K	Buy	30,614 +29,614	+2,961%	+$191K	﹤0.01%	5526
2023 Q1	$7.89K	Hold	1,000	–	–	﹤0.01%	6112
2022 Q4	$1K	Hold	1,000	–	–	﹤0.01%	7064
2022 Q3	$1K	Hold	1,000	–	–	﹤0.01%	7188
2022 Q2	$1K	Hold	1,000	–	–	﹤0.01%	7258
2022 Q1	$2K	Hold	1,000	–	–	﹤0.01%	6972
2021 Q4	$3K	Hold	1,000	–	–	﹤0.01%	6968
2021 Q3	$4K	Hold	1,000	–	–	﹤0.01%	6697
2021 Q2	$5K	Hold	1,000	–	–	﹤0.01%	6444
2021 Q1	$5K	Hold	1,000	–	–	﹤0.01%	6224
2020 Q4	$7K	Hold	1,000	–	–	﹤0.01%	5691
2020 Q3	$10K	Buy	+1,000	New	+$11.8K	﹤0.01%	5296

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings's BLPH Position: Q4 2023 in Review

Osaic Holdings sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 557 shares — an estimated $221 sold.

Osaic Holdings first reported a position in BLPH in Q3 2020 and held it in 13 quarters. The position peaked at $21.1K in Q2 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

Osaic Holdings reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 557 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $221.
Osaic Holdings first reported a position in Bellerophon Therapeutics, Inc. in Q3 2020 and held it in 13 quarters.
Osaic Holdings's Bellerophon Therapeutics, Inc. position peaked at $21.1K in Q2 2023.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.